Current View
Click here to download the PDF file.

The survival rates of the dreaded hematological cancer myeloma has increased significantly, says, Dr. Neeraj Sidharthan, Associate Professor, Blood and Marrow Transplantation, Medical Oncology, Amrita Institute of Medical Sciences, Kochi. There are nine highly effective 'novel agents' that have been approved for treatment of myeloma. "These are helping patients to live longer and providing them with better quality of life," said Dr. Neeraj.

207
PROGRAMS
OFFERED
6
AMRITA
CAMPUSES
15
CONSTITUENT
SCHOOLS
A
GRADE BY
NAAC, MHRD
8th
RANK(INDIA):
NIRF 2018
150+
INTERNATIONAL
PARTNERS